Replacement of calcineurin inhibitors by mycophenolate mofetil: effect on hemoglobine levels.
Suwelack
Barbara
B
Medical Department, University of Muenster, Albert-Schweitzer-Strasse 33, D-48149 Münster, Germany. suwelac@uni-muenster.de
Kobelt
V
V
Hillebrand
U
U
Gerhardt
U
U
Matzkies
F
F
Hohage
H
H
D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D065095:Calcineurin Inhibitors; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000009:adverse effects; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
D065095:Calcineurin Inhibitors; D004791:Enzyme Inhibitors; D006454:Hemoglobins; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus